Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Cobblestone lissencephaly is a rare central nervous system malformation which includes a group of diseases that are characterized by a bumpy (or pebbled) appearance of the cerebral cortex, associated with a thickened cortex, reduction in normal sulcation, ventriculomegaly and reduced, abnormal white matter, as well as brainstem and cerebellum hypoplasia and corpus callosum agenesis. Patients generally present variable degrees of developmental delay, hypotonia and ocular abnomalities, however muscular and ocular involvement may be absent.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for cobblestone lissencephaly.
16 publications have been identified in PubMed for cobblestone lissencephaly. Research spans Case Report / Case Series (47%), Review / Meta-Analysis (27%), and Epidemiology / Natural History (13%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 7 | 47% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 5:49 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about cobblestone lissencephaly
4 |
27% |
Disease patterns and progression | 2 | 13% |
Clinical study results | 1 | 7% |
Laboratory research | 1 | 7% |
Das S (2026). [PMID: 41508885](https://pubmed.ncbi.nlm.nih.gov/41508885/). *Clin Neuropathol*. [Review / Meta-Analysis]
Navolić J (2025). [PMID: 40680886](https://pubmed.ncbi.nlm.nih.gov/40680886/). *Mol Cell Proteomics*. [Basic Science / Preclinical]
Sugiyama R (2025). [PMID: 39798169](https://pubmed.ncbi.nlm.nih.gov/39798169/). *Neuromuscul Disord*. [Case Report / Case Series]
Russ JB (2025). [PMID: 40048696](https://pubmed.ncbi.nlm.nih.gov/40048696/). *Brain*. [Review / Meta-Analysis]
Ishigaki K (2025). [PMID: 40914050](https://pubmed.ncbi.nlm.nih.gov/40914050/). *Brain Dev*. [Review / Meta-Analysis]
Sifre-Ruiz A (2025). [PMID: 40252628](https://pubmed.ncbi.nlm.nih.gov/40252628/). *Rev Esp Patol*. [Case Report / Case Series]
Ishigaki K (2025). [PMID: 40011677](https://pubmed.ncbi.nlm.nih.gov/40011677/). *Sci Rep*. [Epidemiology / Natural History]
Lee SJ (2025). [PMID: 41188778](https://pubmed.ncbi.nlm.nih.gov/41188778/). *BMC Ophthalmol*. [Case Report / Case Series]
Murakami T (2025). [PMID: 40814256](https://pubmed.ncbi.nlm.nih.gov/40814256/). *Neuropsychopharmacol Rep*. [Clinical Trial Publication]
Sato T (2025). [PMID: 39566997](https://pubmed.ncbi.nlm.nih.gov/39566997/). *Tohoku J Exp Med*. [Epidemiology / Natural History]